Variable signaling activity by FOP ACVR1 mutations.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bone

• Publication date

  2017-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bone.2017.10.027PMID 29097342PMCID PMC5866189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neofunction of ACVR1 in fibrodysplasia ossificans progressiva

  2015cited by this paper
• ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A

  2015cited by this paper
• Activin A inhibits BMP-signaling by binding ACVR2A and ACVR2B

  2015cited by this paper
• Alk2 Regulates Early Chondrogenic Fate in Fibrodysplasia Ossificans Progressiva Heterotopic Endochondral Ossification

  2014cited by this paper
• ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant.

  2014cited by this paper
• Activins bind and signal via bone morphogenetic protein receptor type II (BMPR2) in immortalized gonadotrope-like cells.

  2013cited by this paper
• Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation

  2013cited by this paper
• Hyperactive BMP signaling induced by ALK2R206H requires type II receptor function in a Drosophila model for classic fibrodysplasia ossificans progressiva

  2012cited by this paper
• Targeting the TGFβ signalling pathway in disease

  2012cited by this paper
• New insights into the mechanisms of activin action and inhibition.

  2012cited by this paper
• Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva

  2012cited by this paper
• Fibroregulation of Mesenchymal Progenitor Cells by BMP-4 After Traumatic Muscle Injury

  2012cited by this paper
• An Acvr1 R206H knock‐in mouse has fibrodysplasia ossificans progressiva

  2012cited by this paper
• In vitro Analyses of the Dysregulated R206H ALK2 Kinase-FKBP12 Interaction Associated with Heterotopic Ossification in FOP

  2011cited by this paper
• Mouse Embryonic Fibroblasts (MEF) Exhibit a Similar but not Identical Phenotype to Bone Marrow Stromal Stem Cells (BMSC)

  2011cited by this paper
• Molecular Consequences of the ACVR1R206H Mutation of Fibrodysplasia Ossificans Progressiva*

  2010cited by this paper
• Inefficient skeletal muscle repair in inhibitor of differentiation knockout mice suggests a crucial role for BMP signaling during adult muscle regeneration.

  2010cited by this paper
• The fibrodysplasia ossificans progressiva R206H ACVR1 mutation activates BMP-independent chondrogenesis and zebrafish embryo ventralization.

  2009cited by this paper
• ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP‐induced osteoblast differentiation and bone formation

  2009cited by this paper
• BMP heterodimers assemble hetero-type I receptor complexes that pattern the DV axis

  2009cited by this paper
• Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1

  2009cited by this paper
• A rapid and sensitive bioassay to measure bone morphogenetic protein activity

  2007cited by this paper
• A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva

  2006cited by this paper
• Pref-1 (Preadipocyte Factor 1) Activates the MEK/Extracellular Signal-Regulated Kinase Pathway To Inhibit Adipocyte Differentiation

  2006cited by this paper
• Osteogenic Differentiation of Mouse Embryonic Stem Cells and Mouse Embryonic Fibroblasts in a Three-Dimensional Self-Assembling Peptide Scaffold

  2006cited by this paper
• BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.

  2005cited by this paper
• Specificity and versatility in tgf-beta signaling through Smads.

  2005cited by this paper
• SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS

  2005cited by this paper
• Fibrodysplasia Ossificans Progressiva (FOP), a Disorder of Ectopic Osteogenesis, Misregulates Cell Surface Expression and Trafficking of BMPRIA

  2005cited by this paper
• Primary mouse embryonic fibroblasts: A model of mesenchymal cartilage formation

  2004cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-beta family signalling.

  2003cited by this paper
• Bone Morphogenetic Protein-4 Regulation in Fibrodysplasia Ossificans Progressiva

  2003cited by this paper
• Smad-dependent and Smad-independent pathways in TGF-β family signalling

  2003cited by this paper
• Identification and Functional Characterization of Distinct Critically Important Bone Morphogenetic Protein-specific Response Elements in the Id1 Promoter*

  2002cited by this paper
• The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.

  2001cited by this paper
• Crystal Structure of the Cytoplasmic Domain of the Type I TGF β Receptor in Complex with FKBP12

  1999cited by this paper
• Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12.

  1999cited by this paper
• Characterization of bone morphogenetic protein 4 receptor in fibrodysplasia ossificans progressiva.

  1998cited by this paper
• Mechanism of TGFβ receptor inhibition by FKBP12

  1997cited by this paper
• TGF-β signalling from cell membrane to nucleus through SMAD proteins

  1997cited by this paper
• Bone morphogenetic protein 2/4 in early fibromatous lesions of fibrodysplasia ossificans progressiva.

  1997cited by this paper
• TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

  1997cited by this paper
• Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva.

  1996cited by this paper
• The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors.

  1996cited by this paper
• Characterization of the Interaction of FKBP12 with the Transforming Growth Factor-β Type I Receptor in Vivo*

  1996cited by this paper
• Characterization of type I receptors for transforming growth factor-beta and activin.

  1994cited by this paper
• Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing

  1994cited by this paper
• Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors

  1993cited by this paper
• Determination of type I receptor specificity by the type II receptors for TGF-beta or activin.

  1993cited by this paper
• Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.

  1993cited by this paper
• Cloning of a type I TGF-beta receptor and its effect on TGF-beta binding to the type II receptor.

  1993cited by this paper

• Interplay between ALK2R206H mutant receptor and autophagy signaling regulates receptor stability and its chondrogenic functions

  2025cites this paper
• Role of endocrinal dysregulations in traumatic heterotopic ossification pathogenesis.

  2025cites this paper
• Molecular Developmental Biology of Fibrodysplasia Ossificans Progressiva: Measuring the Giant by Its Toe

  2024cites this paper
• BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas

  2024cites this paper
• Activin receptors in human cancer: Functions, mechanisms, and potential clinical applications.

  2024cites this paper
• The Activation of the Fibrodysplasia Ossificans Progressiva-Inducing ALK2-R206H Mutant Depends on the Distinct Homo-Oligomerization Patterns of ACVR2B and ACVR2A

  2024cites this paper
• Functional comparison of human ACVR1 and zebrafish Acvr1l FOP‐associated variants in embryonic zebrafish

  2023influential citation
• Diffuse Intrinsic Pontine Glioma: Molecular Landscape, Evolving Treatment Strategies and Emerging Clinical Trials

  2022cites this paper
• Reduced GS domain serine/threonine requirements of Fibrodysplasia Ossificans Progressiva mutant type I BMP receptor ACVR1 in the zebrafish

  2022influential citation
• Multi-omics therapeutic perspective on ACVR1 gene: from genetic alterations to potential targeting.

  2022cites this paper
• The Intricate Epigenetic and Transcriptional Alterations in Pediatric High-Grade Gliomas: Targeting the Crosstalk as the Oncogenic Achilles’ Heel

  2022cites this paper
• Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways

  2022cites this paper
• Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva

  2021cites this paper
• BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP)

  2021cites this paper
• Rare and intractable fibrodysplasia ossificans progressiva shows different PBMC phenotype possibly modulated by ascorbic acid and propranolol treatment.

  2021cites this paper
• An anti-ACVR1 antibody exacerbates heterotopic ossification by fibro-adipogenic progenitors in fibrodysplasia ossificans progressiva mice

  2021cites this paper
• Comprehensive Analysis of the Expression of TGF-β Signaling Regulators and Prognosis in Human Esophageal Cancer

  2021cites this paper
• An ACVR1R375P pathogenic variant in two families with mild fibrodysplasia ossificans progressiva

  2021cites this paper
• Overexpression of Wild‐Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification

  2021cites this paper
• Activins as Dual Specificity TGF-β Family Molecules: SMAD-Activation via Activin- and BMP-Type 1 Receptors

  2020cites this paper
• When the Nervous System Turns Skeletal Muscles into Bones: How to Solve the Conundrum of Neurogenic Heterotopic Ossification

  2020cites this paper
• Fibrodysplasia ossificans progressiva mutant ACVR1 signals by multiple modalities in the developing zebrafish

  2020cites this paper
• Fibrodysplasia Ossificans Progressiva (FOP): A Disorder of Osteochondrogenesis.

  2020cites this paper
• Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors.

  2020cites this paper
• O-GlcNAcylation Dampens Dpp/BMP Signaling to Ensure Proper Drosophila Embryonic Development.

  2020cites this paper
• Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification

  2019cites this paper
• BMP and mTOR signaling in heterotopic ossification: Does their crosstalk provide therapeutic opportunities?

  2019cites this paper
• Genetics and future therapy prospects of fibrodysplasia ossificans progressiva

  2019cites this paper
• ACVR1 Function in Health and Disease

  2019cites this paper
• Regulation of BMP Signaling by O-GlcNAcylation

  2019cites this paper
• The role of Activin A in fibrodysplasia ossificans progressiva: a prominent mediator

  2019cites this paper
• BMPR2 inhibits activin and BMP signaling via wild-type ALK2

  2018cites this paper
• Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity

  2018cites this paper
• Bone morphogenetic protein receptor signal transduction in human disease

  2018cites this paper
• Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafish.

  2018cites this paper
• BMPR2 inhibits activin- and BMP-signaling via wild type ALK2

  2017cites this paper
• Fibrodysplasia Ossificans Progressiva

  1984cites this paper